A new network, In4Kids, has been launched to facilitate the development of new drugs for children in Ireland and across Europe. Up to now, paediatric patients generally receive ‘smaller doses’ of adult medicines or dilution of therapies as they have not been specifically developed and trialed on children.
Approximately 60% of medicines and therapies used to treat children have not been studied in children, and over 90% have not been studied in infants.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
